Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BNRNASDAQ:EUDANASDAQ:QIPTNASDAQ:TOI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBNRBurning Rock Biotech$3.88-1.9%$5.95$2.62▼$8.99$39.70M0.6714,643 shs3,997 shsEUDAEUDA Health$3.81+2.4%$3.87$1.64▼$6.30$93.83M-0.0572,448 shs84,411 shsQIPTQuipt Home Medical$2.07-5.9%$2.64$2.06▼$4.17$89.20M0.61140,798 shs75,027 shsTOIOncology Institute$1.29-10.4%$0.91$0.13▼$1.63$98.45M0.41722,593 shs441,980 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBNRBurning Rock Biotech-7.49%-15.96%-24.33%-43.97%-48.62%EUDAEUDA Health+0.27%-4.37%+8.45%-17.33%+106.67%QIPTQuipt Home Medical-2.22%-7.56%-7.95%-27.87%-47.74%TOIOncology Institute-2.70%+29.73%+108.64%+349.86%-3.36%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBNRBurning Rock BiotechN/AN/AN/AN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/AN/AN/AN/AQIPTQuipt Home Medical1.9338 of 5 stars3.53.00.00.00.61.70.6TOIOncology Institute0.6702 of 5 stars0.03.00.00.02.71.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBNRBurning Rock Biotech 0.00N/AN/AN/AEUDAEUDA Health 4.00Strong BuyN/AN/AQIPTQuipt Home Medical 3.00Buy$6.25201.93% UpsideTOIOncology Institute 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBNRBurning Rock Biotech$515.82M0.08N/AN/A$10.56 per share0.37EUDAEUDA Health$3.81M24.62N/AN/A($0.30) per share-12.70QIPTQuipt Home Medical$244.72M0.36$0.81 per share2.56$2.47 per share0.84TOIOncology Institute$393.41M0.25N/AN/A$0.77 per share1.68Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBNRBurning Rock Biotech-$92.07M-$1.88N/A∞N/A-83.50%-60.68%-42.30%N/AEUDAEUDA Health-$10.04MN/A0.00N/AN/AN/AN/AN/A5/6/2025 (Estimated)QIPTQuipt Home Medical-$6.76M-$0.17N/AN/AN/A-2.90%-6.70%-2.94%5/13/2025 (Estimated)TOIOncology Institute-$83.07M-$0.71N/A∞N/A-17.63%-186.83%-34.58%5/12/2025 (Estimated)Latest TOI, QIPT, EUDA, and BNR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/25/2025Q4 2024BNRBurning Rock Biotech-$1.3970-$1.08+$0.3170-$1.08N/A$17.27 million3/24/2025Q4 2024TOIOncology Institute-$0.08-$0.14-$0.06-$0.14$109.15 million$100.27 million2/10/2025Q1 2025QIPTQuipt Home MedicalN/A-$0.03N/A-$0.03N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBNRBurning Rock BiotechN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/AQIPTQuipt Home MedicalN/AN/AN/AN/AN/ATOIOncology InstituteN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBNRBurning Rock BiotechN/A3.042.78EUDAEUDA HealthN/A0.13N/AQIPTQuipt Home Medical0.741.220.87TOIOncology Institute5.912.492.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBNRBurning Rock Biotech30.03%EUDAEUDA Health4.35%QIPTQuipt Home Medical42.85%TOIOncology Institute36.86%Insider OwnershipCompanyInsider OwnershipBNRBurning Rock Biotech30.30%EUDAEUDA HealthN/AQIPTQuipt Home Medical13.40%TOIOncology Institute9.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBNRBurning Rock Biotech1,39010.24 million7.14 millionNot OptionableEUDAEUDA Health224.63 millionN/ANot OptionableQIPTQuipt Home Medical80043.09 million37.32 millionOptionableTOIOncology Institute66075.56 million68.38 millionNot OptionableTOI, QIPT, EUDA, and BNR HeadlinesRecent News About These CompaniesWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 17.46%April 3 at 12:18 AM | aaii.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 10.53%April 2 at 9:14 AM | aaii.comThe Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025April 1 at 11:43 AM | msn.comThe Oncology Institute announces launch of the Florida Oncology NetworkMarch 31, 2025 | markets.businessinsider.comTOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1March 31, 2025 | globenewswire.comInsider Buying: The Oncology Institute, Inc. (NASDAQ:TOI) Director Acquires 90,562 Shares of StockMarch 31, 2025 | americanbankingnews.comDaniel Virnich Buys 22,640 Shares of The Oncology Institute, Inc. (NASDAQ:TOI) StockMarch 29, 2025 | marketbeat.comInsider Buying: The Oncology Institute, Inc. (NASDAQ:TOI) Director Buys 90,562 Shares of StockMarch 29, 2025 | marketbeat.comInsider Buying: The Oncology Institute, Inc. (NASDAQ:TOI) CEO Acquires 22,640 Shares of StockMarch 29, 2025 | insidertrades.comQ4 2024 Oncology Institute Inc Earnings CallMarch 26, 2025 | finance.yahoo.comOncology Institute Full Year 2024 Earnings: US$0.86 loss per share (vs US$0.92 loss in FY 2023)March 26, 2025 | uk.finance.yahoo.comThe oncology institute targets profitability and $460M-$480M revenue in 2025March 25, 2025 | msn.comThe Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call TranscriptMarch 25, 2025 | seekingalpha.comOncology Institute (NASDAQ:TOI) Releases Earnings ResultsMarch 25, 2025 | marketbeat.comThe Oncology Institute announces $16.5M private placementMarch 24, 2025 | markets.businessinsider.comThe Oncology Institute sees FY25 revenue $460M-$480MMarch 24, 2025 | markets.businessinsider.comThe Oncology Institute reports Q4 EPS (14c) vs. (21c) last yearMarch 24, 2025 | markets.businessinsider.comThe Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025March 24, 2025 | globenewswire.comThe Oncology Institute Announces $16.5 million Private PlacementMarch 24, 2025 | globenewswire.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 12.48%March 20, 2025 | aaii.comFreeGulliver LLC Grows Stock Holdings in The Oncology Institute, Inc. (NASDAQ:TOI)March 20, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTOI, QIPT, EUDA, and BNR Company DescriptionsBurning Rock Biotech NASDAQ:BNR$3.88 -0.08 (-1.90%) As of 12:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.EUDA Health NASDAQ:EUDA$3.81 +0.09 (+2.42%) As of 12:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.Quipt Home Medical NASDAQ:QIPT$2.07 -0.13 (-5.91%) As of 12:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.Oncology Institute NASDAQ:TOI$1.29 -0.15 (-10.42%) As of 12:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Ecosystem Edge: Joby's Competitive Advantage Intel’s Big Bet on 18A: Will Lip-Bu Tan’s Vision Pay Off? Lamb Weston Stock Rises, Earnings Provide Calm Amidst Chaos Sportsman’s Warehouse Trading Volume Spike Signals Opportunity Broadcom’s VMware Strategy Could Fuel the Next AVGO Rally Arm Holdings Aims for 50% Data Center Market Share Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy? Celsius Heats Up: Acquisition, Analyst Upgrade Fuel Momentum Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
